Loading clinical trials...
Loading clinical trials...
This is a pilot clinical investigation. Patients who meet the eligibility criteria and provide signed informed consent will be randomized to receive either an active product (Uracyst®) or placebo intr...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Watson Pharmaceuticals
NCT07391306 · IC, Interstitial Cystitis and Bladder Pain Syndrome, and more
NCT05737121 · Interstitial Cystitis, Bladder Pain Syndrome
NCT00389142 · Interstitial Cystitis, Bladder Pain Syndrome
NCT05726786 · Bladder Cancer, Interstitial Cystitis, and more
NCT05149573 · Interstitial Cystitis, Chronic Interstitial Cystitis, and more
Surrey, British Columbia
Vancouver, British Columbia
Victoria, British Columbia
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions